Ambee
Ambee Pharmaceuticals PLC, founded in 1976 and listed on the Dhaka and Chittagong Stock Exchanges, manufactures generic pharmaceutical products under WHO cGMP and ISO 9001:2015 certification at its Dhaka facility and distributes them across Bangladesh and to Afghanistan, Myanmar, Cambodia, and Bhutan.
- Company typePublic
- Founded1976
- HeadquartersDhaka, Bangladesh
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ambee does
Ambee Pharmaceuticals PLC is a Bangladeshi generic pharmaceutical manufacturer founded on February 4, 1976, and listed on the Dhaka Stock Exchange (ticker: AMBEE) and the Chittagong Stock Exchange. The company manufactures tablets, capsules, liquids, gels, and injectables across multiple therapeutic categories — including antibiotics (HIFLOX, LEXLO, MYZID, DOXILIN), NSAIDs (AROLAK, HITFLAM, NAPROXIN), PPIs (X-Pro, OM), antihistamines (ACTIZEN, AMBFEX), cardiovascular agents (LOTAS, VEROSPIRON), vitamins and minerals (VITEX GOLD, ZINC-S, AMBEECAL), psychotropics (NOCTIN, REM, SEDUXEN, SERA), and anthelmintics (TRIBEN) — under WHO cGMP and ISO 9001:2015 certified manufacturing at its facility in Tejgaon Industrial Area, Dhaka.
The company's core technology stack is conventional small-molecule generic manufacturing governed by U.S. Drug Authority CGMP standards, with quality systems certified by United Registrar of Systems Ltd. (URS) of the UK. Its principal intangible asset is a joint venture with Medimpex of Budapest, Hungary, dating to 1976, which provides formulation expertise and has scaled to 76 jointly developed products. Ambee monetizes through one-time product sales distributed via a wholly-owned in-house network: a National Distribution Cell in Dhaka and eight regional sales depots across Khulna, Chittagong, Bogra, Sylhet, Barisal, Comilla, Mymensingh, Rangpur, and Rajshahi, supported by ~200 field sales personnel and 150+ distribution staff.
The primary customer base is healthcare consumers across Bangladesh served through chemists and pharmacies, with a secondary push into government and NGO supply contracts in Asia and Africa. International revenue comes from exports to Afghanistan, Myanmar, Cambodia, and Bhutan via distribution partners. Ownership is concentrated in the founding Aziz Mohammad Bhai family; management is led by Chairman Aziz Mohammad Bhai and Managing Director Kazi Tanzzina Ferdous, with a CFO (A.K.M. Khairul Aziz) who has been with the company for 38 years and two recently appointed independent directors (2020, 2021). No revenue, profitability, or fundraising figures are publicly disclosed.
Ambee firmographics
Firmographics- Name
- Ambee
- Legal name
- Ambee Pharmaceuticals PLC
- Website
- https://ambeepharma.com
- Company type
- Public
- Founded year
- 1976
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Ambee Pharmaceuticals PLC, founded in 1976 and listed on the Dhaka and Chittagong Stock Exchanges, manufactures generic pharmaceutical products under WHO cGMP and ISO 9001:2015 certification at its Dhaka facility and distributes them across Bangladesh and to Afghanistan, Myanmar, Cambodia, and Bhutan.
- Ownership category
- akta.pro rank
Ambee industry classification
Industry- Product category
- Generic Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
- akta.pro secondary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
Keywords
Where Ambee is headquartered
LocationHeadquarters
- HQ city
- Dhaka
- HQ country
- Bangladesh
- HQ region
- Asia
Offices11 records
Markets served
Ambee business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D
Revenue model
- Pharmaceutical Product Sales: Ambee Pharmaceuticals generates revenue through the manufacture and sale of pharmaceutical products including tablets, capsules, liquids, gels, and injectables. The company sells through its own distribution network across Bangladesh and exports to neighboring countries.
- Joint Venture Products: Revenue from 76 products developed through joint venture with Medimpex Hungary, including antibiotics, anti-ulcerants, psychotropics, antacids, gels, vitamins, and injectables.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels1 record
Ambee product offering
Product offeringCore offering
Ambee Pharmaceuticals PLC manufactures and sells over 120 generic pharmaceutical formulations including tablets, capsules, liquids, gels, and injectables across multiple therapeutic categories. Products are manufactured at WHO cGMP compliant facilities in Dhaka, Bangladesh, with 76 formulations developed through a joint venture with Medimpex Hungary. The company distributes products nationwide in Bangladesh through its own sales depots and field force, and exports to Afghanistan, Myanmar, Cambodia, and Bhutan via international distribution partners.
Product overview
Ambee Pharmaceuticals PLC is a pharmaceutical manufacturing and distribution company established in 1976 in Bangladesh. The company produces a portfolio of over 76 pharmaceutical products across multiple therapeutic categories including tablets, capsules, liquids, gels, and injectables. The product portfolio includes NO-SPA (Drotaverine Hydrochloride), ACT PLUS (Paracetamol & Caffeine), ZINC-S SYRUP, VITEX GOLD (Multivitamin with Minerals A-Z), AROLAK (Ketorolac Tromethamine), X-Pro 20/40 (Esomeprazole Magnesium Trihydrate), along with antibiotics such as HIFLOX, LEXLO, MYZID, DOXILIN, antihistamines including ACTIZEN and AMBFEX, cardiovascular products like LOTAS and VEROSPIRON, and various other therapeutic medications. The company operates as a WHO cGMP certified manufacturer with ISO 9001:2015 quality management certification and distributes products domestically through a network of sales depots and internationally to markets in Afghanistan, Myanmar, Cambodia, Bhutan, and is expanding to Africa and SAARC regions.
Differentiator
Problem solved
Functional benefit
Products and services
- NO-SPA Drotaverine Hydrochloride antispasmodic available as tablets and injection, used for smooth muscle spasm relief.
- ZINC-S SYRUP Zinc Sulphate Monohydrate oral syrup for mineral supplementation.
- ACT PLUS Paracetamol and Caffeine combination tablet for antipyretic and analgesic use.
- AROLAK Ketorolac Tromethamine NSAID available as tablets and injection for pain and inflammation management.
- X-Pro (Esomeprazole 20mg and 40mg) Esomeprazole Magnesium Trihydrate capsules in 20mg and 40mg strengths for proton pump inhibition / acid reflux treatment.
- VITEX GOLD Multivitamin with Minerals A-Z combined preparation tablets available in 15s and 30s pack sizes for nutritional supplementation.
- VITEX-M TABLET Multi Vitamin with Minerals tablet supplement.
- TRIBEN (Albendazole) Albendazole anthelmintic available as oral suspension and 400mg tablets for parasitic worm infection treatment.
- AMETROL-VT TABLET Metronidazole and Miconazole Nitrate combination tablet for combined antibacterial and antifungal treatment.
- DIPHEDAN TABLET Phenytoin 100mg anticonvulsant tablet for seizure management.
- AFLUZOLE (Fluconazole 50mg and 150mg) Fluconazole antifungal capsules available in 50mg and 150mg strengths for systemic and topical fungal infection treatment.
- ACTIZEN (Cetirizine) Cetirizine Dihydrochloride antihistamine available as oral syrup and 10mg tablets for allergic rhinitis and urticaria.
- AMBFEX (Fexofenadine 120mg and 180mg) Fexofenadine antihistamine tablets in 120mg and 180mg strengths for allergic condition management.
- LOTAS TABLET Losartan Potassium 50mg antihypertensive tablet for blood pressure management.
- KLION (Metronidazole) Metronidazole antiprotozoal available as Benzoyl Metronidazole oral suspension and 400mg tablets for protozoal and anaerobic infections.
- ACT (Paracetamol) Paracetamol antipyretic and analgesic available as 120mg/5ml oral suspension and 500mg tablets for fever and pain relief.
- ALUCTIN CAPSULE Flurazepam 30mg benzodiazepine capsule for sedative and hypnotic treatment.
- NOCTIN TABLET Nitrazepam 5mg benzodiazepine tablet for sedative and hypnotic treatment.
- REM TABLET Bromazepam 3mg benzodiazepine tablet for sedative and anxiolytic treatment.
- SEDUXEN (Diazepam) Diazepam benzodiazepine available as 10mg injection and 5mg tablets for sedative, anxiolytic, and muscle relaxant treatment.
- AMASON TABLET Dexamethasone 0.5mg corticosteroid tablet for anti-inflammatory and immunosuppressive treatment.
- VEROSPIRON (Spironolactone) Spironolactone diuretic available as 25mg standalone tablet and as Spironolactone plus Frusemide combination tablet (VEROSPIRON PLUS) for edema and cardiovascular indications.
- HIFLOX (Ciprofloxacin 500mg and 750mg) Ciprofloxacin fluoroquinolone antibiotic tablets in 500mg and 750mg strengths for bacterial infection treatment.
- LEXLO (Levofloxacin 250mg and 500mg) Levofloxacin Hemihydrate fluoroquinolone antibiotic tablets in 250mg and 500mg strengths for respiratory and urinary tract bacterial infections.
- PREDNISOLONE TABLET Prednisolone 5mg glucocorticoid tablet for anti-inflammatory and immunosuppressive therapy.
- FERRITIN-TR CAPSULE Ferrous Sulphate and Folic Acid combination capsule for iron deficiency anemia treatment and supplementation.
- AMBKUST Montelukast 10mg leukotriene receptor antagonist tablet for asthma and allergic airway disease management.
- MYZID 500 TABLET Azithromycin Dihydrate 500mg macrolide antibiotic tablet for bacterial infection treatment.
- MYCIN SUSPENSION Erythromycin Ethyl Succinate macrolide antibiotic oral suspension for bacterial infection treatment.
- HITFLAM (Diclofenac) Diclofenac Sodium NSAID available as 10gm topical gel, 75mg injection, and 100mg sustained-release tablet for pain and inflammation relief.
- NAPROXIN TABLET Naproxen 500mg NSAID tablet for pain, inflammation, and fever management.
- ADOREX (Domperidone) Domperidone prokinetic available as 5mg/ml pediatric drops, 5mg/5ml oral suspension, and 10mg tablets for gastrointestinal motility disorders.
- OM (Omeprazole 20mg and 40mg) Omeprazole BP proton pump inhibitor capsules in 20mg (100s pack) and 40mg (30s pack) strengths for gastric acid-related disorders.
- VITEX INJECTION Vitamin B-Complex injection for parenteral vitamin supplementation.
- SERA TABLET Sertraline HCL 50mg SSRI tablet for depression and related psychiatric conditions.
- NOSTIS TABLET Glucosamine Sulphate and Chondroitin Sulphate tablet for cartilage formation support in joint health.
- DOXILIN CAPSULE Doxycycline 100mg tetracycline antibiotic capsule for bacterial infection treatment.
- FOLAC TABLET Folic Acid 5mg tablet for vitamin supplementation and prenatal care.
- AMBEECAL (Calcium Carbonate) Calcium Carbonate 500mg tablet (AMBEECAL) and Calcium Carbonate plus Vitamin D3 tablet (AMBEECAL-D) for calcium supplementation and bone health.
Quantifiable outcome
- Established in 1976, with first year sales over 1 Crore BDT
- +1 more outcomes
Companies that use Ambee
Customer profileSegments2 records
Ideal customer profiles2 records
Ambee technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Ambee partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Medimpex HungarycoreAmbee entered into a joint venture with Medimpex of Budapest, Hungary (a famous multinational company). The venture began operations with a modest portfolio of 17 jointly developed products and is now operating at full scale with an expanded range of 76 products. This partnership brings global pharmaceutical expertise to Bangladesh manufacturing operations.
Scale indicators8 records
Recent moves7 records
Expansion highlights4 records
Ambee competitors and assessment
Company assessmentDirect peers
- Renata PLC: Leading Bangladeshi pharma manufacturer (formerly Pfizer Bangladesh) producing generics, animal health, and specialty products. Direct competitor with broader therapeutic coverage than Ambee.
- Aristopharma Limited: Bangladesh-based generic pharmaceutical manufacturer with a broad portfolio of tablets, capsules, liquids, and injectables. Direct competitor in the domestic Bangladesh generics market.
- Drug International Limited: Bangladeshi generic pharmaceutical manufacturer producing tablets, capsules, liquids, and injectables. Closely comparable to Ambee in product categories and Bangladesh market focus.
- Square Pharmaceuticals: Largest pharmaceutical manufacturer in Bangladesh, producing generics across tablets, capsules, liquids, and injectables. Direct competitor to Ambee in domestic Bangladesh generics, also exporting regionally.
- ACI Limited (Pharma Division): Diversified Bangladeshi conglomerate with a significant pharmaceutical division manufacturing generics across multiple therapeutic areas. Competes directly with Ambee in domestic Bangladesh market.
- Healthcare Pharmaceuticals: Bangladesh-based pharmaceutical manufacturer with broad generic portfolio and own nationwide distribution. Comparable mid-sized competitor to Ambee in domestic market.
- Eskayef Pharmaceuticals: Bangladesh-based pharmaceutical manufacturer producing generics in tablets, capsules, liquids, injectables and creams. Directly comparable to Ambee in size, product mix, and distribution model.
- Incepta Pharmaceuticals: One of the top Bangladeshi pharmaceutical companies producing a wide range of generics including tablets, capsules, injectables, and biologics. Comparable in product breadth and domestic distribution model to Ambee.
- Beximco Pharmaceuticals: Major Bangladeshi generic pharma manufacturer with broad therapeutic portfolio and export operations. Competes directly with Ambee across multiple therapeutic categories in Bangladesh and export markets.
- Globe Pharmaceuticals: Bangladeshi generic pharma manufacturer producing a wide range of therapeutic categories. Closely comparable to Ambee in scale, product portfolio, and Bangladesh domestic market focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Ambee social profiles
Digital presenceAmbee compliance and trust
Trust signalCompliance2 records
Ambee financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ambee leadership team
Management profileNumber of profiles
Profiles10 records
Ambee funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ambee M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ambee
What does Ambee do?
Ambee Pharmaceuticals PLC manufactures and sells over 120 generic pharmaceutical formulations including tablets, capsules, liquids, gels, and injectables across multiple therapeutic categories. Products are manufactured at WHO cGMP compliant facilities in Dhaka, Bangladesh, with 76 formulations developed through a joint venture with Medimpex Hungary. The company distributes products nationwide in Bangladesh through its own sales depots and field force, and exports to Afghanistan, Myanmar, Cambodia, and Bhutan via international distribution partners.
Is Ambee a public or private company?
Ambee is a public company. It is classified as public and is currently operating.
When was Ambee founded?
Ambee was founded in 1976. It employs 51 to 100 people.
Where is Ambee based?
Ambee is headquartered in Dhaka, Bangladesh, in the Asia region.
How does Ambee make money?
Two revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are joint Venture Products.
Who are Ambee's main competitors?
Direct peers on record are Renata PLC, Aristopharma Limited, Drug International Limited, Square Pharmaceuticals, ACI Limited (Pharma Division), Healthcare Pharmaceuticals, Eskayef Pharmaceuticals, Incepta Pharmaceuticals, Beximco Pharmaceuticals and Globe Pharmaceuticals.
Does Ambee have an API?
No public API is recorded for Ambee.
What industry is Ambee in?
Ambee's product category is Generic Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of HLAIAJAB, Specialty Pharmaceutical Distributors. Its NAICS code is 325412 and its SIC code is 2834.